Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAP PET/CT in Adults With Tuberculosis
NCT07830771Phase 1Recruiting
- Sponsor
- University of Pennsylvania
- Start
- Sep 2026
- Primary completion
- Sep 2028
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of [18F]-FAPI-74 in Tuberculosis (TB), sponsored by University of Pennsylvania. Primary endpoint: Relationship between change in FAP PET signals in lungs during TB treatment and change in lung structural damage at 6 months. Started Sep 2026; status: recruiting.
02
Drugs
[18F]-FAPI-74
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT07830771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07830771.